Aurora Cannabis Inc.
ACB
3.96 $
1 Tag: +0.25% (+0.01 $)
Der Alarm wird direkt gespeichert, ohne auf die Homepage zu springen.
Kursalarme fuer ACB
Bitte anmelden, um Kursalarme zu sehen und zu speichern.
Finanzen
Unternehmensinfo
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Aktuelle News
-
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid?
Vorschau anzeigen
Aurora's turnaround could make Curaleaf's offer look too low.
-
Curaleaf And Aurora Are Now Sniping At Each Other
Vorschau anzeigen
Like Logan Roy on HBO, Aurora CEO Miguel Martin is fending off a bear hug. We’ll see if a deal gets done.
-
Curaleaf Rejects Aurora Defense, Reiterates $4 Premium Offer
Vorschau anzeigen
In a statement on Monday, Curaleaf rejected Aurora’s assertions of inaccuracies in its unsolicited bid and accused the Canadian firm of using selective metrics to deflect from years of underperformance.
-
Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
Vorschau anzeigen
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s (TSX: ACB) (NASDAQ: ACB) ("Aurora") latest public statements regarding Curaleaf's offer for Aurora:
-
Aurora Cannabis Highlights Inaccuracies In Curaleaf’s Takeover Bid Announcement— CEO Claims Business Is Reaching Pivotal Inflection Point
Vorschau anzeigen
Aurora said its Board, along with a newly formed Special Committee of independent directors, is reviewing Curaleaf's proposal as it determines the future course of action.